Myriad Genetics buy Guggenheim
Start price
14.12.23
/
50%
€19.70
Target price
14.12.24
€21.01
Performance (%)
26.90%
Price
23.08.24
€24.80
Summary
This prediction is currently active. The BUY prediction by Guggenheim currently has a performance of 26.90%. This prediction currently runs until 14.12.24. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Myriad Genetics | -2.362% | -2.362% |
iShares Core DAX® | 1.056% | 1.056% |
iShares Nasdaq 100 | -1.886% | -0.160% |
iShares Nikkei 225® | 2.553% | 4.359% |
iShares S&P 500 | -0.434% | 0.224% |
Comments by Guggenheim for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $23.00 price target on the stock.
Ratings data for MYGN provided by MarketBeat